Tumors of female reproductive systemTumors of female reproductive systemОпухоли женской репродуктивной системы1994-40981999-8627Publishing House ABV Press30310.17650/1994-4098-2009-0-1-2-108-111GYNECOLOGY. NEW TECHNOLOGIESГИНЕКОЛОГИЯ. НОВЫЕ ТЕХНОЛОГИИASSISTED REPRODUCTIVE TECHNOLOGIES FOR FERTILITY PRESERVATION OF CANCER PATIENTSВСПОМОГАТЕЛЬНЫЕ РЕПРОДУКТИВНЫЕ ТЕХНОЛОГИИ В СОХРАНЕНИИ РЕПРОДУКТИВНОЙ ФУНКЦИИ ОНКОЛОГИЧЕСКИХ БОЛЬНЫХKiselevaM. V.КиселёваМ. В.
Russian Federation
AbakushinaE. V.АбакушинаЕ. В.
Russian Federation
abakushina@mail.ruTsybA. F.ЦыбА. Ф.
Russian Federation
Medical Radiology Research Centre of Russian Academy of Medical Science, ObninskГУ МРНЦ РАМН, Обнинск010520091-210811103092014030920142009https://ojrs.abvpress.ru/ojrs/article/view/303

Over the past years the number of young people diagnosed with cancer has been increasing. Aggressive chemotherapy and radiothera- py have resulted in an increased number of long-term cancer survivors of young cancer patients, but major side effects of these treat- ments are ovarian failure and subsequently lead to a loss of fertility. When cancer is diagnosed, patients and oncologists generally focus on treating the disease, and as a result, critical questions about fertility can go unasked or unanswered. If this happens, cancer patients may miss the only opportunity they have to preserve their ability to have a biological child. Fertility preservation should be an integral part of improving the quality of life in cancer survivors.

В последние годы увеличилось число онкологических пациентов молодого возраста. Применение агрессивной химио- и радиотерапии приве- ло к увеличению продолжительности жизни онкологических больных репродуктивного возраста, но главный побочный эффект такого ле- чения — снижение овариального резерва, что впоследствии приводит к потере фертильности. Когда рак диагностирован, пациенты и он- кологи обычно сосредотачиваются на том, чтобы лечить болезнь, и в результате вопросы, касающиеся репродуктивной функции, могут быть не заданы или остаются без ответа. В этом случае онкологические больные могут лишиться единственной возможности сохранить способность иметь своего собственного ребенка. Сохранение фертильности должно быть неотъемлемой частью улучшения качества жизни таких пациентов.

cryopreservationin-vitro fertilizationoocystsintracytoplasmic spermatozoon injectioncryoprotectantкриоконсервацияЭКОооцитыИКСИкриопротектор1. Maltaris T., Seufert R., Fischl F. et al. The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol and Reprod Biol 2007;130:148—55.Maltaris T., Seufert R., Fischl F. et al. The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol and Reprod Biol 2007;130:148—55.2. Donnez J., Godin P.A., Qu J., Nisolle M. Gonadal cryopreservation in the young patient with gynaecological malignancy. Curr Opin Obstet Gynecol 2000;12:1—9.Donnez J., Godin P.A., Qu J., Nisolle M. Gonadal cryopreservation in the young patient with gynaecological malignancy. Curr Opin Obstet Gynecol 2000;12:1—9.3. Carter J. Cancer-related infertility. Gynecol Oncol 2005;99:122—3.Carter J. Cancer-related infertility. Gynecol Oncol 2005;99:122—3.4. Meirow D., Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001;7:535—43.Meirow D., Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001;7:535—43.5. Meirow D., Epstein M., Lewis H. et al. Administration of cyclophos- phamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod 2001;16:632—7.Meirow D., Epstein M., Lewis H. et al. Administration of cyclophos- phamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod 2001;16:632—7.6. Meirow D. Ovarian injury and mod- ern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-onco- logical neoplasias and other cancers. Leuk Lymphoma 1999;33:65—76.Meirow D. Ovarian injury and mod- ern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-onco- logical neoplasias and other cancers. Leuk Lymphoma 1999;33:65—76.7. Sonmezer M., Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004;10:251—66.Sonmezer M., Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004;10:251—66.8. Donnez J., Martinez-Madrid B., Jadoul P. et al. Ovarian tissue cryopreser- vation and transplantation: a review. Hum Reprod Update 2006;12(5):519— 35.Donnez J., Martinez-Madrid B., Jadoul P. et al. Ovarian tissue cryopreser- vation and transplantation: a review. Hum Reprod Update 2006;12(5):519— 35.9. Morice P., Juncker L., Rey A. et al. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril 2000;74:743—8.Morice P., Juncker L., Rey A. et al. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril 2000;74:743—8.10. Morita Y., Perez G.I., Paris F. et al. Oocyte apoptosis is suppressed by disrup- tion of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 2000;6:1109—14.Morita Y., Perez G.I., Paris F. et al. Oocyte apoptosis is suppressed by disrup- tion of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 2000;6:1109—14.11. Paris F., Perez G.I., Fuks Z. et al. Sphingosine 1-phosphate preserves fertil- ity in irradiated female mice without propagating genomic damage in off- spring. Nat Med 2002;9:901—2.Paris F., Perez G.I., Fuks Z. et al. Sphingosine 1-phosphate preserves fertil- ity in irradiated female mice without propagating genomic damage in off- spring. Nat Med 2002;9:901—2.12. Seli E., Tangir J. Fertility preserva- tion options for female patients with malignancies. Curr Opin Obstet Gynecol 2005;173:299—308.Seli E., Tangir J. Fertility preserva- tion options for female patients with malignancies. Curr Opin Obstet Gynecol 2005;173:299—308.13. Pickering S.J., Braude P.R., Johnson M.H. et al. Transient cooling to room temperature can cause irreversible disruption of the meiotic spindle in the human oocyte. Fertil Steril 1990;54:102—8.Pickering S.J., Braude P.R., Johnson M.H. et al. Transient cooling to room temperature can cause irreversible disruption of the meiotic spindle in the human oocyte. Fertil Steril 1990;54:102—8.14. Gosden R.G. Prospects for oocyte banking and in vitro maturation. J Natl Cancer Inst Monogr 2005;34:60—3.Gosden R.G. Prospects for oocyte banking and in vitro maturation. J Natl Cancer Inst Monogr 2005;34:60—3.15. Eroglu A., Toner M., Toth T.L. Beneficial effect of microinjected tre- halose on the cryosurvival of human oocytes. Fertil Steril 2002;77:152—8.Eroglu A., Toner M., Toth T.L. Beneficial effect of microinjected tre- halose on the cryosurvival of human oocytes. Fertil Steril 2002;77:152—8.16. Oktay K., Newton H., Aubard Y. et al. Cryopreservation of immature human oocytes and ovarian tissue: an emerging technology? Fertil Steril 2003;69:1—7.Oktay K., Newton H., Aubard Y. et al. Cryopreservation of immature human oocytes and ovarian tissue: an emerging technology? Fertil Steril 2003;69:1—7.17. Feigin E., Abir R., Fisch B. et al. Laparoscopic ovarian tissue preservation in young patients at risk for ovarian fail- ure as a result of chemotherapy/irradia- tion for primary malignancy. J Pediatr Surg 2007;42:862—4.Feigin E., Abir R., Fisch B. et al. Laparoscopic ovarian tissue preservation in young patients at risk for ovarian fail- ure as a result of chemotherapy/irradia- tion for primary malignancy. J Pediatr Surg 2007;42:862—4.18. Sonmezer M., Shamonki M.I., Oktay K. Ovarian tissue cryopreservation: benefits and risks. Cell Tissue Res 2005;322:125—32.Sonmezer M., Shamonki M.I., Oktay K. Ovarian tissue cryopreservation: benefits and risks. Cell Tissue Res 2005;322:125—32.19. Donnez J., Dolmans M.M., Demylle D. et al. Livebirth after ortho- topic transplantation of cryopreserved ovarian tissue. Lancet 2004;364: 1405—10.Donnez J., Dolmans M.M., Demylle D. et al. Livebirth after ortho- topic transplantation of cryopreserved ovarian tissue. Lancet 2004;364: 1405—10.20. Meirow D., Levron J., Eldar-Geva T. et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005;353:318—21.Meirow D., Levron J., Eldar-Geva T. et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005;353:318—21.21. Hovatta O. Methods for cryopreservation of human ovarian tissue. Reprod BioMed Online 2005;10(6):729—34.Hovatta O. Methods for cryopreservation of human ovarian tissue. Reprod BioMed Online 2005;10(6):729—34.